Where developed Tamsulosin?

Tamsulosin was developed by the pharmaceutical company Boehringer Ingelheim. It was approved for use in the United States in 1997 and is primarily used to treat symptoms of benign prostatic hyperplasia (BPH) in men. The drug works by selectively blocking alpha-1 adrenergic receptors, leading to relaxation of the muscles in the prostate and bladder neck, which helps alleviate urinary symptoms.